Audit on the characteristics of lung cancer patients who receive BSC (best supportive care)

被引：0
|
作者：
Harris, M. [1 ]
Hanna, D. [1 ]
Faivre-Finn, C. [2 ]
Bayman, N. [3 ]
Chittalia, A. [1 ]
Stout, R. [1 ]
Pemberton, L. [3 ]
Califano, R. [4 ]
Burt, P. [1 ]
Blackhall, F. [5 ]
Coote, J. [3 ]
Sheikh, H. [3 ]
Summers, Y. [5 ]
机构：
[1] Christie, Clin Oncol, Manchester, Lancs, England
[2] Christie NHS Fdn Trust, RRR Dept, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Clin Oncol, Manchester, Lancs, England
[4] Christie, Med Oncol, Manchester, Lancs, England
[5] Christie NHS Fdn Trust, Med Oncol, Manchester, Lancs, England
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
10.1016/S0169-5002(16)30183-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
166
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [41] Chemotherapy Plus Best Supportive Care versus Best Supportive Care in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
    Zhong, Chenxi
    Liu, Hongcheng
    Jiang, Liyan
    Zhang, Wei
    Yao, Feng
    PLOS ONE, 2013, 8 (03):
  • [42] Supportive care in lung cancer
    Boyar, M
    Raftopoulos, H
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (02) : 369 - +
  • [43] Best supportive care in advanced lung cancer-more than a label?
    Bowden, Jo
    Fenning, Stephen
    Marron, Brooke
    Macpherson, Catriona
    Boyce, Steinunn
    Wardrope, Varrie
    Macmillan, Karen Campbell
    Johnston, Lucy
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [44] Chemotherapy versus best supportive care for extensive small cell lung cancer
    Pelayo Alvarez, Marta
    Gallego Rubio, Oscar
    Bonfill Cosp, Xavier
    Agra Varela, Yolanda
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [45] Chemotherapy versus best supportive care for extensive small cell lung cancer
    Pelayo Alvarez, Marta
    Westeel, Virginie
    Cortes-Jofre, Marcela
    Bonfill Cosp, Xavier
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (11):
  • [46] Best supportive care in lung cancer trials is inadequately described: a systematic review
    Jack, B.
    Boland, A.
    Dickson, R.
    Stevenson, J.
    Mcleod, C.
    EUROPEAN JOURNAL OF CANCER CARE, 2010, 19 (03) : 293 - 301
  • [47] Taxotere® (TXT) versus best supportive care (BSC) in chemonaive patients with unresectable non-small cell lung cancer (NSCLC):: Final results of the phase iii study
    Roszkowski, K
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S246 - S246
  • [48] Characteristics of Emergency Department Patients Who Receive a Palliative Care Consultation
    Grudzen, Corita R.
    Hwang, Ula
    Cohen, Jason A.
    Fischman, Michael
    Morrison, Sean
    JOURNAL OF PALLIATIVE MEDICINE, 2012, 15 (04) : 396 - 399
  • [49] Phase III study of paclitaxel (Taxol®) (T) versus best supportive care (BSC) in inoperable non-small cell lung cancer (NSCLC)
    Thatcher, N
    Ranson, M
    Anderson, H
    Burt, P
    Davidson, N
    Nicolson, M
    Falk, S
    Carmichael, J
    Washington, T
    Jeynes, A
    ANNALS OF ONCOLOGY, 1998, 9 : 1 - 1
  • [50] ISEL: a Phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC, in patients with advanced non-small-cell lung cancer (NSCLC) who had received one or two prior chemotherapy regimens
    Thatcher, N
    Chang, A
    Parikh, P
    Pemberton, K
    Archer, V
    LUNG CANCER, 2005, 49 : S4 - S4
12345